Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vose

Showing results (531-540 of 891) with videos related to

Pageof 90
Sort By:
Joint Commission Journal on Quality and Patient Safety|April 20, 2011
Establishing a comprehensive networkwide pressure ulcer identification processCourtney Vose, Robert X Murphy, David B Burmeister, et al.
Journal of the Air & Waste Management Association (1995)|March 25, 2014
Changes in weather and climate extremes: state of knowledge relevant to air and water quality in the United StatesThomas C Peterson, Thomas R Karl, James P Kossin, et al.
Blood|July 15, 1990
Comparison of high-dose therapy and autologous bone marrow transplantation for T-cell and B-cell non-Hodgkin's lymphomasJ M Vose, C Peterson, P J Bierman, et al.
Leukemia & Lymphoma|October 11, 2014
Efficacy, safety, pharmacokinetics and pharmacodynamics of SAR245409 (voxtalisib, XL765), an orally administered phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor: a phase 1 expansion cohort in patients with relapsed or refractory lymphomaKyriakos P Papadopoulos, Coumaran Egile, Rodrigo Ruiz-Soto, et al.
Journal of Contemporary Brachytherapy|March 27, 2023
Pain and symptom relief using inhaled methoxyflurane for gynecologic brachytherapy applicator removalAlexandra J Stewart, Ciarna Brooker, Gemma Vose, et al.
Blood|May 1, 1996
Occurrence of the t(2;5)(p23;q35) in non-Hodgkin's lymphomaD D Weisenburger, B G Gordon, J M Vose, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2003
Randomized, multicenter, open-label study of pegfilgrastim compared with daily filgrastim after chemotherapy for lymphomaJ M Vose, M Crump, H Lazarus, et al.
American Journal of Veterinary Research|October 10, 2002
Inheritance of pancreatic acinar atrophy in German Shepherd DogsE Michael Moeller, Jörg M Steiner, Leigh Anne Clark, et al.
Stem Cells (Dayton, Ohio)|July 1, 1995
Granulocyte-macrophage colony-stimulating factor as adjunct therapy in relapsed lymphoid malignancy: implications for economic analyses of phase III clinical trialsC L Bennett, S L George, J M Vose, et al.
Cancer|July 29, 2010
Phase 1 trial of bortezomib plus R-CHOP in previously untreated patients with aggressive non-Hodgkin lymphomaRichard R Furman, Peter Martin, Jia Ruan, et al.
Pageof 90

Showing results (531-540 of 891) with videos related to

Sort By:
Pageof 90
Joint Commission Journal on Quality and Patient Safety|April 20, 2011
Establishing a comprehensive networkwide pressure ulcer identification processCourtney Vose, Robert X Murphy, David B Burmeister, et al.
Journal of the Air & Waste Management Association (1995)|March 25, 2014
Changes in weather and climate extremes: state of knowledge relevant to air and water quality in the United StatesThomas C Peterson, Thomas R Karl, James P Kossin, et al.
Blood|July 15, 1990
Comparison of high-dose therapy and autologous bone marrow transplantation for T-cell and B-cell non-Hodgkin's lymphomasJ M Vose, C Peterson, P J Bierman, et al.
Leukemia & Lymphoma|October 11, 2014
Efficacy, safety, pharmacokinetics and pharmacodynamics of SAR245409 (voxtalisib, XL765), an orally administered phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor: a phase 1 expansion cohort in patients with relapsed or refractory lymphomaKyriakos P Papadopoulos, Coumaran Egile, Rodrigo Ruiz-Soto, et al.
Journal of Contemporary Brachytherapy|March 27, 2023
Pain and symptom relief using inhaled methoxyflurane for gynecologic brachytherapy applicator removalAlexandra J Stewart, Ciarna Brooker, Gemma Vose, et al.
Blood|May 1, 1996
Occurrence of the t(2;5)(p23;q35) in non-Hodgkin's lymphomaD D Weisenburger, B G Gordon, J M Vose, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2003
Randomized, multicenter, open-label study of pegfilgrastim compared with daily filgrastim after chemotherapy for lymphomaJ M Vose, M Crump, H Lazarus, et al.
American Journal of Veterinary Research|October 10, 2002
Inheritance of pancreatic acinar atrophy in German Shepherd DogsE Michael Moeller, Jörg M Steiner, Leigh Anne Clark, et al.
Stem Cells (Dayton, Ohio)|July 1, 1995
Granulocyte-macrophage colony-stimulating factor as adjunct therapy in relapsed lymphoid malignancy: implications for economic analyses of phase III clinical trialsC L Bennett, S L George, J M Vose, et al.
Cancer|July 29, 2010
Phase 1 trial of bortezomib plus R-CHOP in previously untreated patients with aggressive non-Hodgkin lymphomaRichard R Furman, Peter Martin, Jia Ruan, et al.
Pageof 90